[HTML][HTML] Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings
NA Sabry, EED Omar - Pharmacology & Pharmacy, 2011 - scirp.org
Background: Pneumonia is the most common cause of community-acquired infection
requiring ICU admission. 60-87% of patients with severe community acquired pneumonia …
requiring ICU admission. 60-87% of patients with severe community acquired pneumonia …
Association between systemic corticosteroids and outcomes of intensive care unit–acquired pneumonia
OT Ranzani, M Ferrer, M Esperatti, V Giunta… - Critical care …, 2012 - journals.lww.com
Objective: The use of corticosteroids is frequent in critically-ill patients. However, little
information is available on their effects in patients with intensive care unit–acquired …
information is available on their effects in patients with intensive care unit–acquired …
Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial
E Wittermans, SMT Vestjens… - European …, 2021 - Eur Respiratory Soc
Background Adjunctive intravenous corticosteroid treatment has been shown to reduce
length of stay (LOS) in adults hospitalised with community-acquired pneumonia (CAP). We …
length of stay (LOS) in adults hospitalised with community-acquired pneumonia (CAP). We …
Corticosteroid use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia
Rationale: Adults hospitalized for community-acquired pneumonia (CAP) have an increased
risk of myocardial infarction. Corticosteroid treatment lowers CAP morbidity and mortality, but …
risk of myocardial infarction. Corticosteroid treatment lowers CAP morbidity and mortality, but …
Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a …
L Li, SH Hsu, X Gu, S Jiang, L Shang, G Sun, L Sun… - BMJ open, 2020 - bmjopen.bmj.com
Objectives Long-term use of high-dose glucocorticoids can lead to severe
immunosuppression and increased risk of treatment-resistant pneumonia and mortality. We …
immunosuppression and increased risk of treatment-resistant pneumonia and mortality. We …
Pathogen-and antibiotic-specific effects of prednisone in community-acquired pneumonia
In a double-blind, randomised, placebo-controlled trial of hospitalised patients with
community-acquired pneumonia (CAP), we demonstrated shorter time to clinical stability …
community-acquired pneumonia (CAP), we demonstrated shorter time to clinical stability …
When should we use corticosteroids in severe community-acquired pneumonia?
P Póvoa, L Coelho, J Salluh - Current Opinion in Infectious …, 2021 - journals.lww.com
According to the current evidence, corticosteroids are recommended in Pneumocystis
jiroveci pneumonia in HIV-infected patients and recommendations are against its use in …
jiroveci pneumonia in HIV-infected patients and recommendations are against its use in …
[HTML][HTML] Uso de corticoides sistémicos en pacientes adultos hospitalizados por neumonía adquirida en la comunidad
La neumonía adquirida en la comunidad (NAC) es una enfermedad infecciosa común y
potencialmente grave que ocasiona elevada morbilidad y mortalidad. La terapia con …
potencialmente grave que ocasiona elevada morbilidad y mortalidad. La terapia con …